Mar 17, 2026Neurodegenerative DiseaseGut Microbiome Therapies in MS, Alzheimer’s, and ALS: The EvidenceCan probiotics or L. plantarum slow MS, Alzheimer's, or ALS? Reviews find plausible biology, but human trial evidence remains thin.gut microbiomeparkinson's diseasealzheimer's diseasemultiple sclerosisRead article →
Mar 14, 2026Cognitive HealthLifestyle Pilot Shows a Big Alzheimer’s Signal—With CaveatsA 2024 lifestyle trial improved cognition in early Alzheimer's, but its small, open-label design leaves a major question: can it replicate?alzheimer's diseaselecanemabdonanemabcognitive declineRead article →
Feb 24, 2026Aging ResearchFour Aging Brain Studies Reviewed: Zero Actionable EvidenceTwo review articles, a mutant mouse study, and observational data — four aging papers with no intervention evidence and nothing you can actually do about it.alzheimer's diseaseaging clocksneurodegenerationbiomarkersRead article →